These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2002247)

  • 21. Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
    Molderings GJ; Kolck UW; Scheurlen C; Brüss M; Homann J; Von Kügelgen I
    Scand J Gastroenterol; 2007 Sep; 42(9):1045-53. PubMed ID: 17710669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic mast cell disease with gastrointestinal symptoms--a diagnostic questionnaire].
    Molderings GJ; Kolck U; Scheurlen C; Brüss M; Frieling T; Raithel M; Homann J
    Dtsch Med Wochenschr; 2006 Sep; 131(38):2095-100. PubMed ID: 16981082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased leukotriene E4 excretion in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoid syndrome and disorders of systemic mast-cell activation including systemic mastocytosis.
    Roberts LJ
    Endocrinol Metab Clin North Am; 1988 Jun; 17(2):415-36. PubMed ID: 3042393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic mast cell disease (mastocytosis). General aspects and histopathological diagnosis.
    Horny HP; Ruck P; Kröber S; Kaiserling E
    Histol Histopathol; 1997 Oct; 12(4):1081-9. PubMed ID: 9302569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous and systemic manifestations of mastocytosis.
    Alto WA; Clarcq L
    Am Fam Physician; 1999 Jun; 59(11):3047-54, 3059-60. PubMed ID: 10392589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M; Giavina-Bianchi P; Mezzano V; Castells M
    Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification and diagnosis of mastocytosis: current status.
    Metcalfe DD
    J Invest Dermatol; 1991 Mar; 96(3):2S-4S. PubMed ID: 2002248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.
    Valent P; Horny HP; Triggiani M; Arock M
    Int Arch Allergy Immunol; 2011; 156(2):119-27. PubMed ID: 21576982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aleukemic mast cell leukemia (formerly: "malignant mastocytosis"): an extremely rare form of leukemia. A case report and simultaneously a contribution to revised classification of mastocytosis].
    Horny HP; Krokowski M; Feller AC; Hintze G; Sotlar K; Valent P
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):222-8. PubMed ID: 12238313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anesthesia in children with mastocytosis--a case based review.
    Ahmad N; Evans P; Lloyd-Thomas AR
    Paediatr Anaesth; 2009 Feb; 19(2):97-107. PubMed ID: 19207896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mastocytosis: when should it be considered?].
    Comte-Perret S; Bart PA; Spertini F; Leimgruber A
    Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggressive systemic mastocytosis presenting with hepatic cholestasis.
    Kupfer SS; Hart J; Mohanty SR
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):901-5. PubMed ID: 17873616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis.
    Miner PB
    J Invest Dermatol; 1991 Mar; 96(3):40S-43S; discussion 43S-44S. PubMed ID: 2002261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical varieties of mastocytoses.
    Puretić S; Milavec D
    Acta Med Croatica; 2001; 55(2):61-6. PubMed ID: 11505629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
    Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
    J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review.
    Silva I; Carvalho S; Pinto PL; Machado S; Rosado Pinto J
    Allergol Immunopathol (Madr); 2008; 36(3):154-63. PubMed ID: 18680704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.